Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-26
1998-06-09
Lambkin, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
530351, A61K 3152, C07K 100
Patent
active
057634467
ABSTRACT:
In accordance with the present invention, methods are provided for the treatment of visual loss and other neurological dysfunctions in AIDS patients employing agents capable of blocking TNF expression in the central nervous system.
REFERENCES:
patent: 5096906 (1992-03-01), Mandell et al.
Sullivan et al., Inhibition of the Inflammatory Action of Interleukin-1 and Tumor Necrosis Factor (Alpha) on Neutrophil Function by Pentoxifylline, Infection and Immunity, vol. 56:1722-1729 (1988).
Strieter et al., Cellular and Molecular Regulation of Tumor Necrosis Factor Alpha Production by Pentoxifylline, Biochemical and Biophysical Research Communication vol. 155:1230-1236 (1988).
Schade, Ulrich F., Pentoxifylline Increases Survival in Murine Endotoxin Shock and Decreases Formation of Tumor Necrosis Factor, Circulatory Shock vol. 31:171-181 (1990).
Novick et al., New Pharmacological Studies with Pentoxifylline, Biorheology vol. 27:449-454 (1990).
Noel et al., Pentoxifylline Inhibits Lipopolysaccharide-induced Serum Tumor Necrosis Factor and Mortality, Life Sciences vol. 47:1023-1029 (1990).
Biosis Abstract of Pharmatherapeutica, vol. 2, Jul. 1980, pp. 429-438, "Clinical Use of Pentoxifylline in Hemorrhagic Disorders of the Retina".
Kopmels et al., J. Neuroimmunol. (Suppl. 1) 1991 p. 148.
Strieter et al., Biochem. Biophys. Res. Commun., vol. 155, No. 3, 1988, pp. 1230-1236.
Fazely et al., "Pentoxifylline (Trental) Decreases the Replication of the Human Immunodeficiency Virus Type 1 in Human Peripheral . . . , " Blood, 77, pp. 1653 (1991).
Dugel et al., "Tumor Necrosis Factor in AIDS Associated Optic Neuropathy," Invest. Ophthalmol. Visual Sci., 32, (4) 1991, p. 765.
Busse et al, "Neuritis nervi optici--results of an etiological inquiry & therapeutical results," Medline Abstract #80030891, Klin Monatsbl Augenheilkd, 175, 1979.
Dugel Pravin U.
Gill Parkash S.
Madigan Michele
Sadun Alfredo A.
Lambkin Deborah
University of Southern California
LandOfFree
Use of pentoxifylline and other tumor necrosis factor blockers f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pentoxifylline and other tumor necrosis factor blockers f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pentoxifylline and other tumor necrosis factor blockers f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199401